ASTCT CAR-T Therapy Resources
As research and new advanced become available for chimeric antigen receptor (CAR) T Cell Therapy, ASTCT will provide the latest insights into products, eligibility, research and treatment options.
CAR-T Therapy Webinar Series
ASTCT is hosting a six-part webinar series focused on CAR-T Therapies. Webinars will be hosted throughout the year and will cover a variety of topics related to research, advancement, and future of CAR-T.
CAR-T Webinar Series: CAR T Basics and Biology
This webinar will review of CAR-T Biology, the general process of generating CAR-T, CAR-T targets, the future directions of CAR-T biology.
CAR T Webinar Series: Clinical Advances in CAR-T Cell Therapy
This webinar will cover a review of approved CAR-T products, practical aspects of referrals, eligibility, leukapheresis, and more!
CAR T Webinar Series: CAR-T vs. Transplant: Complements or Competitors
This webinar highlights the key areas of CAR T vs. Transplant, including consultation, day to day management, sequential therapy, and the pros and cons of each.
Insights into CAR-T Therapies - Nucleus Plus
Our Nucleus Plus online hubs take deep dives into topics that matter most to the transplantation and cellular therapy community. This hub features content specifically related to emerging CAR-T therapies, treatment options, research and more.
You might also be interested in past articles published on Nucleus:
Pharmacy SIG Literature Update: CAR-T Cells for Mantle Cell Lymphoma and More
ASTCT Submits Letter to CMS on National Coverage Decision for CAR T-cell Therapy for Cancers
New Paper Explores the Application of ASTCT’s Grading System and Implications for Management of CAR T-cell Toxicity
Policy Perspectives: IPPS Final Rule, CMS Final NCD on CAR-T and More
New Study Finds T-Cells Play Unappreciated Role in Acute GVHD
CAR-T Slide Deck
This comprehensive slide library was developed by a group of clinicians that have been working together to develop ongoing educational initiatives about CAR-T therapy since 2017. The library covers several topics including:
- Why CAR-T therapy
- How CAR-T fits into the world of immuno-oncology
- Patient management
- Institutional considerations
Download Slide Deck
The COVID-19 pandemic has significantly impacted the delivery of cellular therapeutics, including CAR T-cells. This impact has extended beyond patient care to include logistics, administration, and distribution of increasingly limited health care resources.
Journal Article: CAR T-Cell Therapy During the COVID-19 Pandemic
Guidance Document: ASH-ASTCT COVID-19 Vaccination for HCT and CAR-T CELL Recipients: Frequently Asked Questions
Discover what ASTCT has to offer the Transplantation and Cellular Therapy Community.
Learn More About Membership Explore Education Offerings